Citation: | WANG Chi, TIAN Hong, GAO Xiangdong, YAO Wenbing. Influence of ubiquitous chromatin opening element on the antibody expression in CHO cells[J]. Journal of China Pharmaceutical University, 2017, 48(1): 96-101. DOI: 10.11665/j.issn.1000-5048.20170115 |
[1] |
Butler M.Animal cell cultures:recent achievements and perspectives in the production of biopharmaceuticals[J].Appl Microbiol Biotechnol,2005,68(3):283-291.
|
[2] |
Barnes LM,Moy N,Dickson AJ.Phenotypic variation during cloning procedures:analysis of the growth behavior of clonal cell lines[J].Biotechnol Bioeng,2006,94(3):530-537.
|
[3] |
Osterlehner A,Simmeth S,Göpfert U.Promoter methylation and transgene copy numbers predict unstable protein production in recombinant Chinese hamster ovary cell lines[J].Biotechnol Bioeng,2011,108(11):2670-2681.
|
[4] |
Yang Y,Mariati,Chusainow J,et al.DNA methylation contributes to loss in productivity of monoclonal antibody-producing CHO cell lines[J].J Biotechnol,2010,147(3/4):180-185.
|
[5] |
Zhang F,Frost AR,Blundell MP,et al.A ubiquitous chromatin opening element(UCOE)confers resistance to DNA methylation-mediated silencing of lentiviral vectors[J].Mol Ther,2010,18(9):1640-1649.
|
[6] |
Antoniou M,Harland L,Mustoe T,et al.Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing[J].Genomics,2003,82(3):269-279.
|
[7] |
Nair AR,Jinger X,Hermiston TW.Effect of different UCOE-promoter combinations in creation of engineered cell lines for the production of Factor VIII[J].BMC Res Notes,2011,4:178.
|
[8] |
Liu S,Tian H,Wang C,et al.Weakening resistance marker for establishing a process of screening high-producing CHO cell lines[J].J China Pharma Univ(中国药科大学学报),2015,46(5):617-622.
|
[9] |
Almo SC,Love JD.Better and faster:improvements and optimization for mammalian recombinant protein production[J].Curr Opin Struct Biol,2014,26:39-43.
|
[10] |
Zhu J.Mammalian cell protein expression for biopharmaceutical production[J].Biotechnol Adv,2012,30(5):1158-1170.
|